Medications Development Division

Background In 1989, the U.S. Congress mandated that an MDP be established within NIDA. In 1990, NIDA created the Medications Development Division (MDD) (now the DPMCDA) to operationalize the goals of the MDP. 

Chemistry and Pharmaceutics Branch Medications Development Division... 

Medications Development Division National Institute on Drug Abuse... 

Charles Grudzinskas Medications Development Division U.S. National Institute on Drug Abuse Rockville, MD... 

Purpose The Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA) includes a Medications Development Program (MDP). The Medications Discovery and Toxicology Branch... 

The Medical Science Division (MSD) within the BER supports fundamental research and technology development in medicine, particularly in the fields of nuclear medicine, imaging sciences, and neurosciences. 

The Health Policy Bureau handles promotion of R D, drug, quasi-drugs, medical devices and sanitary materials production and distribution policies. It is divided in two divisions, the Economic Affairs Division and the Research and Development Division, both having relationship with the pharmaceutical industry. 

Medical Affairs departments are frequently capable of conducting various types of clinical research. The type of research culminating in the further categorization of the efficacy and safety of a new medicine can take the route of conventional phase III clinical development, sometimes conducted by a Medical Affairs division, whereby a new indication is sought. Another approach is to perform necessary clinical trials and seek approval to promote features of benefit-risk that are supported by clinical data, with or without requesting change of registered label use. This phase of... 

Regulatory (or expert) review of plan. Once the multitier validation plan has been developed it is possible to develop a peruse level of confidence by conferring with FDA representatives or experienced industry experts. While most FDA divisions will not permit pre-review conferences, the medical device division is generally accepting of such an approach. 

General electric permselective membranes , published by Medical Development Operation Chemical and Medical Division, General Electric Co. 

Giorgio Terenghi Histochemistry Department, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK Scott V. Tingey Du Pont Agricultural Products, E. I. du Pont de Nemours and Company, Wilmington, DE Claire B. Wheeler Research and Development Division, Amersham International pic, Amersham, UK... 

It was much easier to separate medical produas from the rest of RCC on a financial statement than it was to disentai e businesses that had been part of the same enterprise for decades. The equipment producdon plant went with the medical products division, but it had always manufactured the commercial irradiators, Gammacells, source capsules and shipping containers that were now products of RCC. The medical products division, for its part, was dependent on the cobalt-60 branch of RCC to produce its therapy sources. Connecdons that had developed naturally as the company grew now had to be arranged by contracmal agreement. 

The worst part of separating the division ftom RCC, however, was the human cost. Working relationships that had developed over years were wrenched apart as employees suddenly found themselves in different organizations. Those who went to the medical products division had good reason to envy the brighter prospects of those who stayed with RCC. After carrying the enterprise for decades, it seemed as if they had been arbitrarily categorized as losers and left behind. 

Chemical Division and the Mechanical Division, each of which was engaged in research and development activities the Plants Division, which was responsible for manufacturing the Property Division, to which supply responsibilities were delegated the Chemical Warfare School and CWS troops. " Later a Safety and Inspection Division and a Medical Research Division were activated. 

Gwyn Morgan BVSc PhD MRCVS is Vice President of Safety Assessment in the Research and Development Division of SmithKline Beecham Pharmaceuticals, and formerly was a lecturer in Veterinary Comparative Pathology at the Medical... 

Air Force. 1990. Development and validation of methods for applying pharmacokinetic data in risk assessment Volume n. Trichloroethylene. Wright-Patterson Air Force Base, OH U.S. Air Force, Air Force Systems Command, Harry G. Armstrong Medical Research Laboratory, Human Systems Division. NTIS No. AD-A237 366. 

Meanwhile, the Chief of the Clinical Research Division, the Chief of the Medical Laboratories and the Scientific Director of the Chemical Research and Development Laboratory (CRDL) were all saying No, most assuredly no to the young major. Since he apparently could only take yes for an answer, he relayed my lone positive response to a higher level. There, he found his sought-... 

Hughes, W.F. Importance of mustard burns of the eye as judged by WW I statistics and recent accidents. IN National Research Council, Division of Medical Sciences, Committee on Treatment of Gas Casualties. Fasciculus on Chemical Warfare Medicine, Volume I Eye. Prepared for the Committee on Medical Research of the Office of Scientific Research and Development. 

Nicotine in tobacco has always been used for medicinal purposes. Nicotine solutions made from soaking tobacco leaves in water have been used as pesticides for several hundred years. In modern times, numerous pharmaceutical companies have explored nicotines use for treating diseases. Nicotines most prevalent medicinal use is for smoking cessation in the form of alternate delivery systems such as gums and dermal patches. Nicotine is used medically for numerous conditions and its use is being explored in additional areas including pain relievers, attention deficit disorder medications and medications associated with Alzheimer s disease, Parkinson disease, colitis, herpes, and tuberculosis. Because of nicotines potential therapeutic use, several large tobacco companies have developed pharmaceutical divisions. 

---